PUBLISHER: The Business Research Company | PRODUCT CODE: 1957779
PUBLISHER: The Business Research Company | PRODUCT CODE: 1957779
Sexually transmitted disease (STD) self-testing refers to the process in which individuals collect their own samples to test for STDs outside of a clinical setting. This approach provides private, convenient, and timely detection of infections such as chlamydia, gonorrhea, HIV, and syphilis using at-home kits or mail-in laboratory services.
The main types of STD self-testing samples include blood-based tests, urine-based tests, and oral-based tests. Blood-based tests use a small blood sample, typically obtained via a finger prick, to detect infections such as HIV, syphilis, and hepatitis at early stages. These tests are distributed through multiple channels, including hospital pharmacies, retail pharmacies, and online pharmacies, and are used for applications such as chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) testing, syphilis testing, HIV testing, and others.
Tariffs have impacted the STD self-testing market by increasing costs of imported diagnostic kits, blood collection devices, and oral swab collection tools. Segments like blood-based and oral-based testing kits are particularly affected, with North America and Europe facing higher import duties due to reliance on international suppliers. While tariffs have raised operational and consumer costs, they have also encouraged local manufacturing, innovation in kit development, and expansion of domestic distribution networks.
The sexually transmitted disease (std) self-testing market research report is one of a series of new reports from The Business Research Company that provides sexually transmitted disease (std) self-testing market statistics, including sexually transmitted disease (std) self-testing industry global market size, regional shares, competitors with a sexually transmitted disease (std) self-testing market share, detailed sexually transmitted disease (std) self-testing market segments, market trends and opportunities, and any further data you may need to thrive in the sexually transmitted disease (std) self-testing industry. This sexually transmitted disease (std) self-testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The sexually transmitted disease (std) self-testing market size has grown strongly in recent years. It will grow from $1.52 billion in 2025 to $1.67 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to limited awareness about std testing, stigma associated with visiting clinics, reliance on hospital-based testing, lack of convenient testing options, growing incidence of sexually transmitted diseases.
The sexually transmitted disease (std) self-testing market size is expected to see strong growth in the next few years. It will grow to $2.42 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to adoption of digital health platforms, integration of multi-sample at-home testing kits, rising government awareness campaigns, increasing telehealth consultations, development of rapid and accurate diagnostic technologies. Major trends in the forecast period include rising demand for at-home std testing kits, increasing awareness of sexual health and early diagnosis, growth in telehealth and remote consultation services, expansion of online and retail pharmacy distribution channels, integration of multi-sample testing solutions (blood, urine, oral).
The rising incidence of syphilis is expected to drive the growth of the sexually transmitted disease (STD) self-testing market in the coming years. Syphilis is a sexually transmitted infection that causes sores on the body and can result in serious health complications if untreated. The increase in syphilis cases is largely due to reduced consistent condom use, especially among populations engaging in high-risk sexual behaviors. STD self-testing enables private and convenient at-home screening for syphilis, promoting early diagnosis. Early detection ensures timely treatment, reduces complications, and prevents further transmission. For instance, in September 2025, the Centers for Disease Control and Prevention reported approximately 209,253 syphilis cases in 2023, a 1% increase from 207,269 cases in 2022. Therefore, the rising incidence of syphilis is propelling the growth of the STD self-testing market.
Key companies in this market are focusing on developing advanced products, such as over-the-counter (OTC) sample collection kits, to encourage early detection and timely treatment. These kits allow individuals to collect samples, including urine or swabs, at home without a prescription, providing a private and convenient testing option. For example, in August 2023, iHealth Labs Inc., a US-based digital health company, launched the CheckMeSafe home collection kit for HIV and syphilis. This FDA-approved kit enables users aged 18 and older to collect blood samples at home, mail them to a lab using a prepaid overnight label, and receive confidential results within two days. The kit offers high accuracy, with sensitivity rates up to 99.9% for HIV and 99.5% for syphilis, and all analyses are conducted in CLIA-certified, CAP-accredited laboratories.
In December 2024, OraSure Technologies Inc., a US-based provider of home diagnostic tests and sample management solutions, acquired Sherlock Biosciences for an undisclosed amount. Through this acquisition, OraSure aims to expand its at-home diagnostics portfolio by integrating Sherlock's CRISPR-based molecular technology to develop rapid OTC self-tests for STIs such as chlamydia and gonorrhea, enabling lab-quality results at home within minutes. Sherlock Biosciences is a US-based company specializing in clinical trials for rapid OTC STI diagnostics.
Major companies operating in the sexually transmitted disease (std) self-testing market are Abbott Laboratories, Viatris Inc., Hologic Inc., OraSure Technologies Inc., LifeCell International, LetsGetChecked Health Inc., Visby Medical Inc., Everlywell Inc., Guangzhou Wondfo Biotech Co. Ltd., NOWDiagnostics Inc., bioLytical Laboratories Inc., Atomo Diagnostics Limited, myLAB Box Inc., BioSure UK Ltd., JAL Medical (S) Pte Ltd., TBD Health Inc., Recombigen Laboratories Private Limited, Alpine Biomedicals Pvt. Ltd., Homed-IQ B.V., Newfoundland Diagnostics Pvt. Ltd.
North America was the largest region in the sexually transmitted disease (STD) self-testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted disease (std) self-testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the sexually transmitted disease (std) self-testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The sexually transmitted disease (STD) self-testing market consists of revenues earned by entities by providing services such as telehealth consultations, digital result delivery, follow-up care coordination, and online pre-test counselling. The market value includes the value of related goods sold by the service provider or included within the service offering. The sexually transmitted disease (STD) self-testing market includes sales of sample collection devices, buffer solutions or reagents, at-home diagnostic kits, mobile app-based test tracking tools, and smartphone-compatible test devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Sexually Transmitted Disease (STD) Self-Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses sexually transmitted disease (std) self-testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for sexually transmitted disease (std) self-testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sexually transmitted disease (std) self-testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.